Conference Coverage

Spinal cord stimulation may help diabetic neuropathy


 

FROM AAN 2023

Improvement in symptom severity and quality of life

After the wound from the implant has completely healed, Dr. Petersen said patients using the devices do not have any activity restrictions outside of magnetic interference, such as MRIs. “I’ve had people go back-country kayaking, scuba diving, fishing with their grandkids, all sorts of all sorts of things. If patients need to go through a scanner of any kind, they should ask whether it’s safe for pacemakers since these devices are like a “pacemaker for pain.

“I had a patient bring solar chargers with him so that he could recharge his battery in the backwoods while kayaking because that’s the level of improvement in pain that he got – from barely being able to walk down the hall to feeling comfortable being off the grid and active again,” Dr. Petersen said. “Those kinds of improvements in quality of life are massive.”

The study findings may also suggest that spinal cord stimulation can benefit a broader population of patients experiencing neuropathic pain, Dr. Markman said.

“There’s an extraordinary unmet need for treatments for neuropathy, and one important question here is the extent to which diabetic peripheral neuropathy and the response that we’re seeing here is a proxy for a broader effect across many neuropathies that are caused by other conditions other than diabetes,” Dr. Markman said. “There’s a lot of reason to think that this will be helpful not just for diabetes-related neuropathic pain, but for other types of neuropathic pain that have similar clinical presentations or clinical symptom patterns to diabetic peripheral neuropathy.”

The study was funded by Nevro, who manufactures the devices. Dr. Petersen and Dr. Markman both reported consulting with, receiving support from, holding stock options with, and serving on the data safety monitoring boards and advisory boards of numerous pharmaceutical companies.

Pages

Recommended Reading

Denosumab boosts bone strength in glucocorticoid users
MDedge Endocrinology
‘Goodie bag’ pill mill doctor sentenced to 2 decades in prison
MDedge Endocrinology
NSAIDs linked to heart failure risk in diabetes
MDedge Endocrinology
‘A huge deal’: Millions have long COVID, and more are expected
MDedge Endocrinology
Mind the geriatrician gap
MDedge Endocrinology
A patient named ‘Settle’ decides to sue instead
MDedge Endocrinology
Physician pleads guilty to 52 counts in opioid scheme
MDedge Endocrinology
U.S. vs. French guidelines for osteoporosis treatment
MDedge Endocrinology
Telehealth doctor indicted on health care fraud, opioid distribution charges
MDedge Endocrinology
COVID can mimic prostate cancer symptoms
MDedge Endocrinology